UPC (Universe Pharmaceuticals) Other Long Term Assets: $-0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UPC Universe Pharmaceuticals Inc UPC
66 GF Score
Price $3.16
GF Value $2.81
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Universe Pharmaceuticals Other Long Term Assets?

Universe Pharmaceuticals UPC -9.20% 66 Other Long Term Assets is $-0.00 Mil as of Mar. 2026. GuruFocus rates UPC with a GF Score™ of 66/100 and a GF Value™ of $2.81 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Universe Pharmaceuticals's other long-term assets for the quarter that ended in Mar. 2026 was $-0.00 Mil.

Universe Pharmaceuticals's quarterly other long-term assets declined from Mar. 2025 ($-0.00 Mil) to Sep. 2025 ($-0.00 Mil) but then increased from Sep. 2025 ($-0.00 Mil) to Mar. 2026 ($-0.00 Mil).

Universe Pharmaceuticals's annual other long-term assets declined from Sep. 2023 ($0.63 Mil) to Sep. 2024 ($0.00 Mil) and declined from Sep. 2024 ($0.00 Mil) to Sep. 2025 ($-0.00 Mil).

Universe Pharmaceuticals Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Universe Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universe Pharmaceuticals Other Long Term Assets Chart

Universe Pharmaceuticals Annual Data
Trend Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Long Term Assets
Get a 7-Day Free Trial 0.87 1.35 0.63 0.00 -0.00

Universe Pharmaceuticals Semi-Annual Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.00 -0.00 -0.00 -0.00
UPC
66GF Score
Universe Pharmaceuticals Inc UPC
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Universe Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $-0.00 Mil mean?
Universe Pharmaceuticals (UPC) has a Other Long Term Assets of $-0.00 Mil as of Mar. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Universe Pharmaceuticals and its competitors.
Is Universe Pharmaceuticals' Other Long Term Assets too high?
Universe Pharmaceuticals' current Other Long Term Assets is $-0.00 Mil. Overall, Universe Pharmaceuticals has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' Other Long Term Assets compare to NPHC and CBIH?
Universe Pharmaceuticals' Other Long Term Assets of $-0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Drug Manufacturers company?
A good Other Long Term Assets depends on the Drug Manufacturers industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Universe Pharmaceuticals and its competitors. Universe Pharmaceuticals's current Other Long Term Assets is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.81, compared to a current price of $3.16 — trading 12.5% above its estimated fair value. The current Other Long Term Assets is $-0.00 Mil. Universe Pharmaceuticals' overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current Other Long Term Assets is $-0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Universe Pharmaceuticals (UPC) Overvalued in 2026?

Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be overvalued. The current stock price of $3.16 is trading 12.5% above its estimated GF Value™ of $2.81. GuruFocus considers Universe Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for UPC:

  • Other Long Term Assets: $-0.00 Mil
  • GF Value™: $2.81 vs. price of $3.16 (12.5% above fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universe Pharmaceuticals Business Description

Address 265 Jingjiu Avenue, Jinggangshan Economic & Technological Development Zone, Jiangxi, Ji’an, CHN, 343100
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
66GF Score

Get the complete analysis for UPC

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.16
Price
$2.81
GF Value